AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q1 2021 Results - Earnings Call Transcript
Aquestive Therapeutics, Inc. (AQST) Q1 2021 Earnings Conference Call May 05, 2021, 08:00 AM ET Company Participants Stephanie Carrington - IR Keith Kendall - President and CEO Ernie Toth - Interim CFO Daniel Barber - SVP and COO Conference Call Participants Gary Nachman - BMO Capital Markets Jason Butler - JMP Securities Shveta Dighe - Wedbush Thomas Flaten - Lake Street Capital Ram Selvaraju - H.C. Wainwright Presentation Operator Good morning and welcome to Aquestive Therapeutics First Quarter 2021 Conference Call. [Operator Instructions] I would now like to introduce your host for today's conference call, Ms. Stephanie Carrington, Aquestive Investor Relations. Please begin. Stephanie Carrington Thank you, operator. Good morning and welcome to today’s call. On today’s call, I am joined by Keith Kendall, President and Chief Executive Officer and Ernie Toth, Interim Chief Financial Officer, who are going to provide an overview of recent business developments and performance in
For further details see:
Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q1 2021 Results - Earnings Call Transcript